Could miltefosine be used as a therapy for toxoplasmosis?

被引：35

作者：

Eissa, Maha M. ^{[1
]}

Barakat, Ashraf M. A. ^{[2
]}

Amer, Eglal I. ^{[1
]}

Younis, Layla K. ^{[3
]}

机构：

[1] Univ Alexandria, Dept Med Parasitol, Fac Med, Alexandria, Egypt

[2] Natl Res Ctr, Dept Zoonot Dis, Cairo, Egypt

[3] Univ Alexandria, Fac Med, Dept Pathol, Alexandria, Egypt

来源：

EXPERIMENTAL PARASITOLOGY | 2015年 / 157卷

关键词：

Toxoplasma gondii; Miltefosine; RH strain; Me49; strain; Chronic toxoplasmosis; Electron microscopy; IN-VITRO ACTIVITY; HEXADECYLPHOSPHOCHOLINE MILTEFOSINE; GONDII INFECTION; CYTOCHROME-B; MOUSE MODEL; SULFADIAZINE; ATOVAQUONE; MECHANISMS; PYRIMETHAMINE; EFFICACY;

D O I：

10.1016/j.exppara.2015.06.005

中图分类号：

R38 [医学寄生虫学]; Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ; 100103 ;

摘要：

Toxoplasmosis is a zoonotic protozoal disease affecting more than a billion people worldwide. The shortfalls of the current treatment options necessitate the development of non-toxic and well-tolerated, efficient alternatives especially against the cyst form. The current study was undertaken to investigate, for the first time, the potential potency of miltefosine against Toxoplasma gondii infection in acute and chronic experimental toxoplasmosis. Results showed that there is no evidence of anti-parasitic activity of miltefosine against T. gondii tachyzoites in acute experimental toxoplasmosis. However, anti-parasitic activity of miltefosine against T. gondii cyst stage in chronic experimental toxoplasmosis could not be excluded as demonstrated by significant reduction in brain cyst burden. Moreover, considerable morphological changes in the cysts were revealed by light and electron microscopy study and also by amelioration of pathological changes in the brain. Future studies should focus on enhancement of anti-toxoplasma activity of miltefosine against chronic toxoplasmosis using formulation based nanotechnology. To the best of our knowledge, this is the first study highlighting efficacy of miltefosine against chronic toxoplasmosis, thus, increasing the list of diseases that can be targeted by this drug. (C) 2015 Elsevier Inc. All rights reserved.

引用

页码：12 / 22

页数：11

共 66 条

[11] Rediscovering the sweet spot in drug discovery [J].

Brown, D ;

Superti-Furga, G .

DRUG DISCOVERY TODAY, 2003, 8 (23) :1067-1077

[12] Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents [J].

Chaturvedi, Devdutt ;

Goswami, Abhishek ;

Saikia, Partha Pratim ;

Barua, Nabin C. ;

Rao, Paruchuri G. .

CHEMICAL SOCIETY REVIEWS, 2010, 39 (02) :435-454

[13] Purine salvage pathways in the apicomplexan parasite Toxoplasma gondii [J].

Chaudhary, K ;

Darling, JA ;

Fohl, LM ;

Sullivan, WJ ;

Donald, RGK ;

Pfefferkorn, ER ;

Ullman, B ;

Roos, DS .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (30) :31221-31227

[14] Significant Reduction of Brain Cysts Caused by Toxoplasma gondii after Treatment with Spiramycin Coadministered with Metronidazole in a Mouse Model of Chronic Toxoplasmosis [J].

Chew, Wai Kit ;

Segarra, Ignacio ;

Ambu, Stephen ;

Mak, Joon Wah .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (04) :1762-1768

[15] Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide:: a possible antimalarial mechanism [J].

Choubey, Vinay ;

Maity, Pallab ;

Guha, Mithu ;

Kumar, Sanjay ;

Srivastava, Kumkum ;

Puri, Sunil Kumar ;

Bandyopadhyay, Uday .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) :696-706

[16] Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy [J].

Chugh, Pauline ;

Bradel-Tretheway, Birgit ;

Monteiro-Filho, Carlos Mr ;

Planelles, Vicente ;

Maggirwar, Sanjay B. ;

Dewhurst, Stephen ;

Kim, Baek .

RETROVIROLOGY, 2008, 5 (1)

[17] Azithromycin Inhibits Vertical Transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae) [J].

Costa, I. N. ;

Angeloni, M. B. ;

Santana, L. A. ;

Barbosa, B. F. ;

Silva, M. C. P. ;

Rodrigues, A. A. ;

Rostkowsa, C. ;

Magalhaes, P. M. ;

Pena, J. D. O. ;

Silva, D. A. O. ;

Mineo, J. R. ;

Ferroa, E. A. V. .

PLACENTA, 2009, 30 (10) :884-890

[18] Efficacy of azithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey [J].

Degerli, K ;

Kilimcioglu, AA ;

Kurt, Ö ;

Tamay, AT ;

Özbilgin, A .

ACTA TROPICA, 2003, 88 (01) :45-50

[19] Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective? [J].

Dissous, Colette ;

Grevelding, Christoph G. .

TRENDS IN PARASITOLOGY, 2011, 27 (02) :59-66

[20] Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii [J].

Djurkovic-Djakovic, O ;

Milenkovic, V ;

Nikolic, A ;

Bobic, B ;

Grujic, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (06) :981-987

← 1 2 3 4 5 6 7 →